Drug Companies File Lawsuits To Block Medicare Price Negotiations, Claiming Policy Is Unconstitutional
- Drugmakers have filed multiple lawsuits attempting to halt Medicare price negotiations authorized under the Inflation Reduction Act.
- Pharmaceutical companies argue negotiations will set lower prices across the healthcare system, reducing revenues.
- Industry claims negotiating authority exceeds government power and violates constitutional rights.
- Legal challenges seen as effort to get conflicting rulings and accelerate cases to the Supreme Court.
- Drug companies are also waging a PR campaign asserting lower prices will stifle innovation and limit new treatments.
Boston Globe 